Access cutting-edge neovascular (wet) age-related macular degeneration treatment through this clinical trial at a research site in Erie. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Erie location
Preparing your pre-screening questions…
Access neovascular (wet) age-related macular degeneration specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related neovascular (wet) age-related macular degeneration treatment provided free
Check if you qualify for this neovascular (wet) age-related macular degeneration clinical trial in Erie, PA
No-Cost Study Care
Local to Erie
Convenient for PA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This Phase 1b/2a study will primarily investigate the safety and tolerability of EYC-0305 delivered by intravitreal (IVT) injection every 24 weeks in patients with neovascular (wet) age-related macular degeneration (AMD). The pharmacokinetics (PK) and immunogenicity of EYC-0305, and the effect on disease activity and vision will also be evaluated.
Sponsor: Eyconis INC.
Yes, this clinical trial (NCT07587515) has an active research site in Erie, PA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for neovascular (wet) age-related macular degeneration treatment options in Erie, PA, this clinical trial (NCT07587515) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Erie research site is actively enrolling participants for this clinical trial. You'll receive care from experienced neovascular (wet) age-related macular degeneration specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all neovascular (wet) age-related macular degeneration clinical trials near you to find additional studies recruiting in your area.
See all essential tremor clinical trials recruiting in Erie — not just this study.
Browse Essential Tremor Trials in Erie →